Backed by Research.

Background

BPC-157 (Body Protection Compound-157) is a synthetic peptide derived from a protein naturally found in human gastric juice. It was first identified by Croatian researcher Predrag Sikiric and has since been the subject of over 100 published studies, primarily focused on tissue protection and repair mechanisms ¹.

Reported Mechanism of Action

Research suggests BPC-157 may work through multiple pathways: promoting angiogenesis (new blood vessel formation), upregulating growth hormone receptors, modulating the nitric oxide system, and influencing several growth factor pathways including VEGF and FGF ².

Key Research Findings

• Studies on Achilles tendon transection in rats showed accelerated healing rates and improved tensile strength ³
• Research on inflammatory bowel disease models suggests protective effects on intestinal mucosa ⁴
• Studies on muscle and ligament injury models demonstrated faster healing markers ⁵
• Research on brain injury models suggested neuroprotective properties ⁶

Stability

Lyophilized BPC-157 is shelf-stable at room temperature for several months. Once reconstituted, refrigeration is recommended and the compound is typically stable for 2–4 weeks under cold storage.

Background

TB-500 is a synthetic version of an active region of thymosin beta-4 (TB4), a naturally occurring peptide present in nearly all human and animal cells. TB4 was originally isolated from the thymus gland and has been studied extensively for its role in cellular repair, wound healing, and tissue regeneration ⁷.

Reported Mechanism of Action

Research suggests TB-500's effects are primarily mediated through actin regulation. By binding to G-actin and sequestering it, TB-500 may influence cell migration, blood vessel formation, and the body's natural healing cascade ⁸.

Key Research Findings

• Cardiac tissue repair studies showed promising regenerative effects post-injury ⁹
• Studies on corneal wound healing demonstrated accelerated epithelial repair ¹⁰
• Research on skin wound models showed improved healing markers and reduced scarring ¹¹
• Studies suggest potential applications in musculoskeletal recovery research

Common Pairing

In research contexts, TB-500 is often studied alongside BPC-157 as a complementary recovery protocol. The combination is sometimes referred to as the "Wolverine Stack" in research literature due to the dual focus on tissue repair pathways.

Background

Retatrutide is a next-generation triple receptor agonist developed by Eli Lilly that activates GLP-1, GIP, and glucagon receptors simultaneously. It represents the third generation of incretin-based research compounds, following semaglutide (single agonist) and tirzepatide (dual agonist) ¹².

Reported Mechanism of Action

By engaging three metabolic receptor pathways simultaneously, retatrutide is hypothesized to influence multiple aspects of energy regulation: glucose metabolism (GLP-1), insulin sensitivity (GIP), and energy expenditure (glucagon). The combined activation produces metabolic effects that exceed what single or dual agonists have demonstrated in published trials ¹³.

Key Research Findings

• Phase 2 clinical trial published in NEJM showed significant body composition changes at 48 weeks ¹⁴
• Studies demonstrated dose-dependent metabolic effects across the trial population ¹⁵
• Research on cardiovascular markers showed favorable changes in trial participants
• Currently in Phase 3 trials with results pending

Research Context

Retatrutide is not yet approved by the FDA. It remains in clinical trials, which is why it is exclusively available for research use at this time. Published data from Eli Lilly's trials is the primary source of current scientific information.

Background

CJC-1295 (without DAC) is a growth hormone releasing hormone (GHRH) analog, while ipamorelin is a selective growth hormone secretagogue. When combined, they target two complementary pathways of growth hormone regulation. This pairing is one of the most-studied secretagogue combinations in published research ¹⁶.

Reported Mechanism of Action

CJC-1295 stimulates the pituitary's natural GHRH receptors, while ipamorelin binds to the ghrelin receptor (GHS-R) to trigger growth hormone release. Unlike older secretagogues, ipamorelin is selective and does not significantly affect cortisol or prolactin levels in published research ¹⁷.

Key Research Findings

• Studies showed dose-dependent increases in growth hormone pulse amplitude ¹⁸
• Research demonstrated preservation of the body's natural GH pulsatility pattern ¹⁹
• Ipamorelin showed selective activity without affecting cortisol, prolactin, or aldosterone ²⁰
• Combined use has been studied for synergistic effects on GH release patterns

Why Combined

CJC-1295 amplifies the "wave" while ipamorelin triggers the "pulse" — researchers combine them to study amplified GH release while preserving natural pulsatile patterns, rather than overriding the body's regulatory systems.

Background

GHK-Cu is a naturally occurring tripeptide-copper complex first identified in human plasma. Levels of GHK in the body decline significantly with age — from approximately 200 ng/ml at age 20 to 80 ng/ml at age 60 — which has driven extensive research into its biological roles ²¹.

Reported Mechanism of Action

Research suggests GHK-Cu acts as a signaling molecule that may influence the expression of hundreds of human genes — many related to tissue regeneration, antioxidant defense, and DNA repair. Its copper-binding properties also appear central to its biological activity ²².

Key Research Findings

• Gene expression studies showed GHK-Cu may modulate over 30% of human genes ²³
• Research on skin tissue showed effects on collagen, elastin, and glycosaminoglycan production ²⁴
• Studies suggest antioxidant effects via copper-mediated free radical scavenging ²⁵
• Research on hair follicle models showed effects on growth and pigmentation markers

Unique Properties

GHK-Cu's copper binding gives it distinctive characteristics — the complex has a recognizable blue color when reconstituted, due to the copper-peptide bond. This is a normal and expected property, not an indicator of contamination.